Eslicarbazepine Acetate (BIA 2-093) as Monotherapy in Patients With Newly Diagnosed Partial-onset Seizures
Clinical trial NCT02484001 · COMPLETED
Trial details
- NCT number
- NCT02484001
- Sponsor
- Bial - Portela C S.A.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2018-09-11
- Enrollment
- 206
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.